Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 10, 2012, Pages 753-760

  Roig, Ingrid L ^a   Darouiche, Rabih O ^a,c   Musher, Daniel M ^a,c   Trautner, Barbara W ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Houston Center for Quality of Care and Utilization Studies   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Defibrillators; Endocarditis; MRSA; Pacemakers

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD VESSEL GRAFT; CENTRAL VENOUS CATHETER; CEREBROVASCULAR ACCIDENT; DEFIBRILLATOR; DEVICE INFECTION; DEVICES; ELECTRONIC MEDICAL RECORD; FEMALE; HEART ABSCESS; HEART FAILURE; HEART VALVE PROSTHESIS; HUMAN; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PACEMAKER; PATHOGENESIS; POPULATION RESEARCH; PROSTHETIC VALVE DYSFUNCTION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; CATHETER-RELATED INFECTIONS; CATHETERS; CROSS INFECTION; ENDOCARDITIS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS;

EID: 84866669176     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.678882     Document Type: Article

References (43)

1. Lomas JM, Martinez-Marcos FJ, Plata A, Ivanova R, Galvez J, Ruiz J, et al. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 2010;16:1683-90.
2. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4.
3. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profi le of 1536 patients in Australia. Eur Heart J 2010;31: 1890-7.
4. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identifi ed cases with follow-up. Clin Infect Dis 1999;28:106-14.
5. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012-21.
6. Martin-Davila P, Fortun J, Navas E, Cobo J, Jimenez-Mena M, Moya JL, et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005;128:772-9.
7. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005;41:507-14.
8. Fernandez Guerrero ML, Gonzalez Lopez JJ, Goyenechea A, Fraile J, de Gorgolas M. Endocarditis caused by Staphyloco-ccus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 2009;88:1-22.
9. Lamas CC, Eykyn SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 1998;79:442-7.
10. Benito N, Miro JM, de Lazzari E, Cabell CH, del Rio A, Altclas J, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009;150:586-94.
11. Fowler VG Jr, Justice A, Moore C, Benjamin DK Jr, Woods CW, Campbell S, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphyloco-ccus aureus bacteremia. Clin Infect Dis 2005;40:695-703.
12. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92:879-85.
13. Rekik S, Trabelsi I, Hentati M, Hammami A, Jemaa MB, Hachicha J, et al. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis. Clin Exp Nephrol 2009; 13:350-4.
14. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the infl u-ence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008;198:336-43.
15. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46(Suppl 5):S344-9.
16. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphy-lococcus aureus as a public-health threat. Lancet 2006; 368:874-85.
17. Lescure FX, Biendo M, Douadi Y, Schmit JL, Eveillard M. Changing epidemiology of methicillin-resistant Staphylococ-cus aureus and effects on cross-transmission in a teaching hospital. Eur J Clin Microbiol Infect Dis 2006;25:205-7.
18. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003;187:1452-9.
19. Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008;47:1287-97.
20. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008;168:2095-103.
21. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-73.
22. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011;8:1678-85.
23. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 2011;34:450-9.
24. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defi brillator infection. Mayo Clin Proc 2008;83:46-53.
25. Le Dolley Y, Thuny F, Mancini J, Casalta JP, Riberi A, Gouriet F, et al. Diagnosis of cardiac device-related infective endocarditis after device removal. JACC Cardiovasc Imaging 2010;3:673-81.
26. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifi cations to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
27. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococ-cus aureus: 1999-2008. Arch Intern Med 2012;172:363-5.
28. Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010;152:497-504, W175.
29. Chrissoheris MP, Libertin C, Ali RG, Ghantous A, Bekui A, Donohue T. Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis. Clin Cardiol 2009;32:E48-54.
30. Nielsen J, Kolmos HJ, Espersen F. Staphylococcus aureus bacteraemia among patients undergoing dialysis - focus on dialysis catheter-related cases. Nephrol Dial Transplant 1998; 13:139-45.
31. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjew-ski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare benefi ciaries: 1990-1999. Am Heart J 2004;147:582-6.
32. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8.
33. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-8.
34. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defi brillators: results of a large prospective study. Circulation 2007;116:1349-55.
35. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, et al. Device-related infection among patients with pacemakers and implantable defi brillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 2010;21:786-90.
36. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 1994;73: 299-305.
37. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defi brillator infections. J Am Coll Cardiol 2007;49:1851-9.
38. Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing Clin Electrophysiol 2008;31:548-53.
39. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacter-emia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.
40. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434.
41. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sor-rentino RA, Greenfi eld RA, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defi brillators. Circulation 2001; 104:1029-33.
42. Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC. Infections of implantable cardioverter defi brillators: approach to management. Clin Infect Dis 1993;17:679-85.
43. Kaasch AJ, Fowler VG Jr, Rieg S, Peyerl-Hoffmann G, Birkholz H, Hellmich M, et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis 2011;53:1-9.